PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014-Reference-Cited by-同舟云学术

PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014

Published:2015-07 Issue:1 Volume:116 Page:27-34
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Konert Tom,Vogel Wouter,MacManus Michael P.,Nestle Ursula,Belderbos José,Grégoire Vincent,Thorwarth Daniela,Fidarova Elena,Paez Diana,Chiti Arturo,Hanna Gerard G.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference70 articles.

1. Positron Emission Tomography with 18Fluorodeoxyglucose in Radiation Treatment Planning for Non-small Cell Lung Cancer;Ung;J Thorac Oncol,2011

2. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis;Gould;Ann Intern Med,2003

3. High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy;MacManus;Int J Radiat Oncol Biol Phys,2001

4. NICE Clinical Guideline: Lung cancer: The diagnosis and treatment of lung cancer. National Institute for Health and Care Excellence, April 2011. Available at http://www.nice.org.uk/guidance/CG121/chapter/introduction accessed 17th July 2014.

5. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer;Cerfolio;Ann Thorac Surg,2004

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of digital positron emission tomography/computed tomography on the delineation of clinical target volume in advanced lung cancer;Molecular and Clinical Oncology;2023-11-06

2. The Role of PET/CT in Lung Cancer Radiotherapy;Nuclear Medicine Seminars;2023-11-01

3. The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada;Frontiers in Oncology;2023-08-23

4. Protocol letter: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study (InGReS) – A Phase 1 multicentre feasibility study;Radiotherapy and Oncology;2023-06

5. Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trial;Radiotherapy and Oncology;2023-04